Explore more publications!
West Virginia Healthcare Press
Got News to Share?

West Virginia Healthcare Press: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on West Virginia Healthcare Press.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 4, 2025

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
November 4, 2025

PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance

Indeterminate GlobeNewswire
Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update
November 4, 2025

Alvotech Announces Webcast on November 13, 2025 to Report Financial Results for the First Nine Months of 2025 and Provide a Business Update

Indeterminate GlobeNewswire
Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody
November 4, 2025

Spyre Therapeutics Announces Positive Interim Phase 1 Results for SPY003, Its Novel, Half-Life Extended anti-IL-23 Antibody

Indeterminate GlobeNewswire
Cardiff Oncology to Participate in Two Upcoming Investor Conferences
November 4, 2025

Cardiff Oncology to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2025

Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 4, 2025

Opus Genetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR
November 4, 2025

Soleno Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on U.S. Launch of VYKAT(TM) XR

Indeterminate GlobeNewswire
Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 4, 2025

Avadel Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
November 4, 2025

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Supernus Announces Third Quarter 2025 Financial Results
November 4, 2025

Supernus Announces Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences
November 4, 2025

Ultragenyx Announces Sale of a Portion of Future North American Royalties on Crysvita® (burosumab) for $400 Million to OMERS Life Sciences

Indeterminate GlobeNewswire
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
November 4, 2025

Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference

Indeterminate GlobeNewswire
Jushi Holdings Inc. Reports Third Quarter 2025 Financial Results
November 4, 2025

Jushi Holdings Inc. Reports Third Quarter 2025 Financial Results

Indeterminate GlobeNewswire
Cytokinetics to Participate in November Investor Conferences
November 4, 2025

Cytokinetics to Participate in November Investor Conferences

Indeterminate GlobeNewswire
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent
November 4, 2025

Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

Indeterminate GlobeNewswire
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
November 4, 2025

Day One Reports Third Quarter 2025 Financial Results and Corporate Progress

Indeterminate GlobeNewswire
MedPro Healthcare Staffing’s Patty Jeffrey, RN, Honored at the 2025 Excellence in Healthcare Awards
November 4, 2025

MedPro Healthcare Staffing’s Patty Jeffrey, RN, Honored at the 2025 Excellence in Healthcare Awards

Indeterminate GlobeNewswire
Smart Health Diagnostics Company Appoints Sarah Barry as Lead Controller to Oversee Finance Operations in Commercial Stage
November 4, 2025

Smart Health Diagnostics Company Appoints Sarah Barry as Lead Controller to Oversee Finance Operations in Commercial Stage

Indeterminate GlobeNewswire
Women’s Health Collective Canada and Partners Call for Bold Investment in Women’s Health to Close the Gap Once and for All
November 4, 2025

Women’s Health Collective Canada and Partners Call for Bold Investment in Women’s Health to Close the Gap Once and for All

Indeterminate GlobeNewswire
L’Association canadienne pour l’équité en santé des femmes et ses partenaires réclament un investissement audacieux dans la santé des femmes afin de combler définitivement les inégalités
November 4, 2025

L’Association canadienne pour l’équité en santé des femmes et ses partenaires réclament un investissement audacieux dans la santé des femmes afin de combler définitivement les inégalités

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions